@article{repository6140,
       publisher = {Atlantis Press},
         journal = {Advances in Health Sciences Research},
           title = {In Vitro Study of Kaempferia galanga L. Compound, {\ensuremath{\delta}}- 3-Carene, Against 5-Lipoxygenase},
          volume = {33},
           pages = {443--444},
          author = {Supandi Supandi, Supandi},
             url = {http://repository.uhamka.ac.id/id/eprint/6140/},
        abstract = {Kaempferia galanga has anti-inflammatory activity and worth developing as lipoxygenase inhibitors. The aim of this study was to determined {\ensuremath{\delta}}-3-carene, one of the potential compounds of K. galanga, as a lipoxygenase inhibitor. The LOX-inhibitor activity was tested in-vitro. The result showed that the IC50 of {\ensuremath{\delta}}-3-carene was 23.10 {\ensuremath{\mu}}M, which was less potential compare to zileuton (7.54 {\ensuremath{\mu}}M). The study showed that K. galanga contains possible active components that could be developed as 5-LOX-inhibitor.}
}